Table 4. MACCE during follow up.
| Variables | All (n=128)† | Chronic CAD (n=65)† |
|---|---|---|
| Myocardial infarction | 3 (2.3) | 1 (1.5) |
| Repeat revascularization by means of PCI | 18 (14.1) | 10 (15.4) |
| Repeat revascularization by means of CABG | 0 | 0 |
| Stroke | 4 (3.1) | 4 (6.2) |
| Fatalities | 28 (21.9) | 10 (15.4) |
| Cardiac-related fatalities | 7 (5.5) | 4 (6.2) |
| MACCE (total) | 47 (36.7) | 19 (29.2) |
Values are presented as n (%). †, 92.8% follow up rate for the entire cohort, corresponding to 128 out of 138, 10 patients were lost to follow up; 94.2% follow up rate for the chronic CAD subgroup, corresponding to 65 out of 69, 4 patients were lost to follow up. MACCE, major adverse cardiac and cerebral events; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.